2-(4-Chlorobenzamido)-4-(methylsulfonyl)butanoic acid

Catalog No.: 
ACEYRO058
CAS No.: 
1103964-06-2
Molecular Formula: 
C12H14ClNO5S
Molecular Weight: 
319.77
2-(4-Chlorobenzamido)-4-(methylsulfonyl)butanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$82.00InquiryInquiry
100mg95%$115.00In stockInquiry
250mg95%$156.00InquiryInquiry
1g95%$298.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-Chlorobenzamido)-4-(methylsulfonyl)butanoic acid
IUPAC Name2-(4-chlorobenzamido)-4-(methylsulfonyl)butanoic acid
MDL No.MFCD08729194
Molecular FormulaC12H14ClNO5S
Molecular Weight319.77
SMILESO=C(O)C(NC(C1=CC=C(Cl)C=C1)=O)CCS(=O)(C)=O
InChI KeyZSBFDIPIJCQQCV-UHFFFAOYSA-N
Synonym2-[(4-CHLOROBENZOYL)AMINO]-4-(METHYLSULFONYL)BUTANOIC ACID;Butanoic acid, 2-[(4-chlorobenzoyl)amino]-4-(methylsulfonyl)-;2-(4-Chlorobenzamido)-4-(methylsulfonyl)butanoic acid;2-(4-Chlorobenzcarboxcarboxcarboxamido)-4-(methylsulfonyl)butanoic acid
CAS No.1103964-06-2

Synthetic Route by SureRoute

1. ACEYRO058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEYRO058 route product structure diagram
    ACEYRO0581103964-06-2In Stock
Inquiry

2. ACEYRO058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYRO058 route product structure diagram
    ACEYRO0581103964-06-2In Stock
Inquiry

3. ACEYRO058 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACEYRO058 route product structure diagram
    ACEYRO0581103964-06-2In Stock
Inquiry

Comments (0)